Anúncio
Anúncio
MESO
Mesoblast Limited - ADR
18.57
USDPatrocinado
+0.29
+1.56%
06 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
18.59
+0.01
+0.05%
Relatórios de Lucros MESO
Rácio de surpresa positiva
MESO separação 8 de 10 últimas estimativas.
80%
Próximo Relatório
Data do Próximo Relatório
25 de fev. de 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/-$0.15
Mudanças implicadas de Q-- -- (Revenue/ EPS)
--
/--
Mudanças implicadas de Q2 25 (Revenue/ EPS)
--
/--
Mesoblast Limited - ADR earnings per share and revenue
On --, MESO reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q2 26, 4 analistas forecast an EPS of -0.15 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Citius Oncology, Inc. Common Stock
Report Date
23 de dez. de 2025 Para Q4 25
Estimativa
-$0.12
Real
-$0.06
Surpresa
+50.98%
FAQ
What were Mesoblast Limited - ADR's earnings and revenue for the latest quarter Q-- --?
For Q-- --, Mesoblast Limited - ADR reported EPS of --, Inline estimates by --, and revenue of --, -- -- expectations.
How did the market react to Mesoblast Limited - ADR's Q-- -- earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Mesoblast Limited - ADR expected to report next?
The next earning report is scheduled for 25 de fev. de 2026.
What are the forecasts for Mesoblast Limited - ADR's next earnings report?
Based on 4
analistas, Mesoblast Limited - ADR is expected to report EPS of -$0.15 and revenue of -- for Q2 2026.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio